Buparlisib hydrochloride
CAS: 1312445-63-8
Ref. 3D-FB103659
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado |
Información del producto
Nombre:
Buparlisib hydrochloride
Descripción:
Buparlisib hydrochloride is an experimental drug that inhibits the function of a protein called phosphoinositide 3-kinase (PI3K), which is involved in cell signaling pathways. The PI3K pathway plays a role in cancer development and progression, including tumor growth, invasiveness, and metastasis. Buparlisib hydrochloride is undergoing clinical trials for the treatment of cancers such as breast cancer and lung cancer. It has been found to have antitumor activity in vivo by inhibiting tumor tissue formation and inhibiting the growth of tumors that are resistant to hormone therapy.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
446.85 g/mol
Fórmula:
C18H21F3N6O2•HCl
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
